Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review studyJacques Cadranel, Keunchil Park, Oscar Arrieta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter studyMiklos Pless, Karim Belhadj, Hans D Menssen, et al.
Cancer|April 19, 2016
Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009Dorothee Gramatzki, Silvia Dehler, Elisabeth Jane Rushing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)Thomas Ruhstaller, Miklos Pless, Daniel Dietrich, et al.
European Journal of Cancer (Oxford, England : 1990)|April 16, 2023
Predictive value of radiological response, pathological response and relapse-free survival for overall survival in neoadjuvant immunotherapy trials: pooled analysis of 29 clinical trialsRuncong Nie, Foping Chen, Mariano Provencio, et al.
Medical Physics|May 13, 2020
Comparison of robust to standardized CT radiomics models to predict overall survival for non-small cell lung cancer patientsDiem Vuong, Marta Bogowicz, Sarah Denzler, et al.
EJNMMI Research|August 21, 2021
Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imagingCarol Oliveira, Florian Amstutz, Diem Vuong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2008
A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancerRodryg Ramlau, Elisabeth Quoix, Janusz Rolski, et al.
BMC Cancer|July 25, 2024
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 studyTakaaki Tokito, Oleksii Kolesnik, Jens Sørensen, et al.
British Journal of Cancer|April 17, 2019
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)Alessandra Curioni-Fontecedro, Jean Yannis Perentes, Hans Gelpke, et al.
Pageof 9